Author Index

A

  • Abbas, Azza Hasan Gaucher disease: Recent advances in the diagnosis and management. [6.2, Issue 2, 2022, Pages 6-10]
  • Abbas, Neven Diagnostic value of of Long Non-Coding RNA ZFAS1 as a Potential Biomarker for Hepatocellular Carcinoma [6.2, Issue 2, 2022, Pages 18-24]
  • Abdalla, Abdelfattah Castleman disease as an unusual cause of ascites : Case report [6.2, Issue 2, 2022, Pages 1-3]
  • Abd ElFattah, Fardous Platelet count/spleen diameter ratio as a predictor of high-risk esophageal varices in patients with liver cirrhosis [6.2, Issue 2, 2022, Pages 25-30]
  • Abozeid, Fatma Diagnostic value of of Long Non-Coding RNA ZFAS1 as a Potential Biomarker for Hepatocellular Carcinoma [6.2, Issue 2, 2022, Pages 18-24]
  • Aeriba, Mohammed Platelet count/spleen diameter ratio as a predictor of high-risk esophageal varices in patients with liver cirrhosis [6.2, Issue 2, 2022, Pages 25-30]
  • Awad, Mahmoud M Platelet count/spleen diameter ratio as a predictor of high-risk esophageal varices in patients with liver cirrhosis [6.2, Issue 2, 2022, Pages 25-30]

D

  • Diasty, Muhammad Incidence of hepatocellular carcinoma one year after direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis; A multicenter study [6.2, Issue 2, 2022, Pages 11-17]

E

  • Elabassy, Lamiaa Diagnostic value of of Long Non-Coding RNA ZFAS1 as a Potential Biomarker for Hepatocellular Carcinoma [6.2, Issue 2, 2022, Pages 18-24]
  • Eladl, Ahmed Castleman disease as an unusual cause of ascites : Case report [6.2, Issue 2, 2022, Pages 1-3]
  • ElDesoky, Abd ElMohsen Platelet count/spleen diameter ratio as a predictor of high-risk esophageal varices in patients with liver cirrhosis [6.2, Issue 2, 2022, Pages 25-30]
  • El-Emam, Ola Incidence of hepatocellular carcinoma one year after direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis; A multicenter study [6.2, Issue 2, 2022, Pages 11-17]
  • Elgamal, Ayman Incidence of hepatocellular carcinoma one year after direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis; A multicenter study [6.2, Issue 2, 2022, Pages 11-17]
  • Elhammady, Dina Diagnostic value of of Long Non-Coding RNA ZFAS1 as a Potential Biomarker for Hepatocellular Carcinoma [6.2, Issue 2, 2022, Pages 18-24]
  • ElHawary, Galal Platelet count/spleen diameter ratio as a predictor of high-risk esophageal varices in patients with liver cirrhosis [6.2, Issue 2, 2022, Pages 25-30]
  • Elmahdi, Essam Incidence of hepatocellular carcinoma one year after direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis; A multicenter study [6.2, Issue 2, 2022, Pages 11-17]

H

  • Habeeb, Maha Diagnostic value of of Long Non-Coding RNA ZFAS1 as a Potential Biomarker for Hepatocellular Carcinoma [6.2, Issue 2, 2022, Pages 18-24]
  • Hassanin, Fetouh Gaucher disease: Recent advances in the diagnosis and management. [6.2, Issue 2, 2022, Pages 6-10]

I

  • Ibrahem, Maha Incidence of hepatocellular carcinoma one year after direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis; A multicenter study [6.2, Issue 2, 2022, Pages 11-17]

R

  • Rabea, Mohamed Gaucher disease: Recent advances in the diagnosis and management. [6.2, Issue 2, 2022, Pages 6-10]
  • Raj, Rishi Metabolic Associated Fatty Liver Disease as the New Nomenclature for Nonalcoholic Fatty Liver Disease [6.2, Issue 2, 2022, Pages 4-5]
  • Ramadan, Ahmed Castleman disease as an unusual cause of ascites : Case report [6.2, Issue 2, 2022, Pages 1-3]

S

  • Saif, Maha Diagnostic value of of Long Non-Coding RNA ZFAS1 as a Potential Biomarker for Hepatocellular Carcinoma [6.2, Issue 2, 2022, Pages 18-24]
  • Schalaan, Mona Gaucher disease: Recent advances in the diagnosis and management. [6.2, Issue 2, 2022, Pages 6-10]
  • Seif, Seham Castleman disease as an unusual cause of ascites : Case report [6.2, Issue 2, 2022, Pages 1-3]
  • Shaband, Nora Castleman disease as an unusual cause of ascites : Case report [6.2, Issue 2, 2022, Pages 1-3]

T

  • Taha, Khaled Incidence of hepatocellular carcinoma one year after direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis; A multicenter study [6.2, Issue 2, 2022, Pages 11-17]

Y

  • Yassen, Ahmed Diagnostic value of of Long Non-Coding RNA ZFAS1 as a Potential Biomarker for Hepatocellular Carcinoma [6.2, Issue 2, 2022, Pages 18-24]

Z

  • Zaki, Maysaa Diagnostic value of of Long Non-Coding RNA ZFAS1 as a Potential Biomarker for Hepatocellular Carcinoma [6.2, Issue 2, 2022, Pages 18-24]